Pregnancy outcomes and risk factors for low birth weight and preterm delivery among HIV-infected pregnant women in Guangxi, China

被引:17
|
作者
Yu Lan [1 ]
Li Wen-ying [2 ]
Chen, Ray Y. [3 ]
Tang Zhi-rong [4 ]
Pang Jun [5 ]
Gui Xiu-zhi [6 ]
Meng Xiu-ning [7 ]
Zhang Fu-jie [1 ,8 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China
[2] USCDC, Global AIDS Program, Beijing Off, Beijing 100000, Peoples R China
[3] US Embassy, US Natl Inst Hlth, Natl Inst Allergy & Infect Dis, Beijing 100000, Peoples R China
[4] Prov Ctr Dis Control & Prevent, Outpatient Clin, Nanning 530000, Guangxi, Peoples R China
[5] 4 Infect Dis Hosp Nanning, Dept Obstet & Gynecol, Nanning 530000, Guangxi, Peoples R China
[6] Maternal & Child Care Serv Hosp Liuzhou, Liuzhou 545001, Guangxi, Peoples R China
[7] Maternal & Child Care Serv Hosp Hengxian, Hengxian 530300, Guangxi, Peoples R China
[8] Capital Med Univ, Beijing Ditan Hosp, Beijing 100015, Peoples R China
关键词
pregnancy outcome; low birth weight; preterm delivery; HIV; pregnant women; TO-CHILD TRANSMISSION; IMMUNODEFICIENCY-VIRUS-INFECTION; ANTIRETROVIRAL THERAPY; MATERNAL HIV; IN-UTERO; MORTALITY; INFANT; TYPE-1; PROGRESS; DISEASE;
D O I
10.3760/cma.j.issn.0366-6999.2012.03.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Six provinces in China accounted for 70%-80% of all reported HIV/AIDS cases in the country in 2009 and five provinces accounted for 78% of all reported mother-to-child transmission (MTCT) of HIV cases. Because Guangxi belonged to both groups, the Prevention of Mother-to-Child Transmission (PMTCT) Plus program was established there to understand better low birth weight (LBW) and preterm delivery (PD) birth outcomes and their associated risk factors better. Methods Pregnancy outcomes were examined among HIV-infected pregnant women who enrolled in the PMTCT Plus program from June 2006 to February 2009 in Guangxi, China. Multivariate Logistic regression analysis was used to explore the risk factors associated with LBW (<2500 g) and PD (gestational age <37 weeks). Results The prevalence of LBW and PD among 194 HIV-positive mothers was 19.6% (38/194) and 9.8% (19/194), respectively. Multivariate Logistic regression analysis showed that CD4 cell count <100 cell/mu l (multivariate-adjusted odds ratio (AOR) 5.52; 95% Cl 1.11-25.55) and CD4 cell count 100-199 cells/mu l (AOR 3.40; 95% Cl 1.03-11.25, compared to CD4 cell count >= 350 cells/mu l), gestational age <37 weeks (AOR 4.38; 95% Cl 1.29-14.82, compared to >= 37 weeks), maternal weight <45 kg (AOR 5.64; 95% Cl 1.09-29.07) and maternal weight 45-54 kg (AOR 3.55; 95% Cl 1.31-9.60, compared to >= 55 kg) at enrollment, and HIV RNA 00 000 copies/ml at enrollment (AOR 4.22; 95% Cl 1.24-14.32) and 20 000-99 999 (AOR 2.77; 95% Cl 1.01-7.77, compared to <20 000 copies/ml) were associated with a higher risk of LBW. For PD, only maternal injection drug use as the route of HIV transmission (AOR 5.30; 95% Cl 1.33-21.14, compared to those infected with HIV through sexual transmission) was significantly associated with a higher risk of PD. Conclusions Lower CD4 cell count and higher HIV RNA viral load at enrollment were associated with LBW. Optimal antenatal care, including earlier antenatal screening and HIV diagnosis, is critical to earlier PMTCT prophylaxis and/or HIV treatment to prevent transmission of HIV to the infant and also to prevent LBW pregnancy outcomes. Chin Med J 2012;125(3):403-409
引用
收藏
页码:403 / 409
页数:7
相关论文
共 50 条
  • [1] Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine
    Lambert, JS
    Watts, DH
    Mofenson, L
    Stiehm, ER
    Harris, DR
    Bethel, J
    Whitehouse, J
    Jimenez, E
    Gandia, J
    Scott, G
    O'Sullivan, MJ
    Kovacs, A
    Stek, A
    Shearer, WT
    Hammill, H
    van Dyke, R
    Maupin, R
    Silio, M
    Fowler, MG
    AIDS, 2000, 14 (10) : 1389 - 1399
  • [2] Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIV
    Traisathit, Patrinee
    Mary, Jean Yves
    Le Coeur, Sophie
    Thantanarat, Sudanee
    Jungpichanvanich, Sivaporn
    Pornkitprasarn, Witaya
    Gomutbutra, Vorapin
    Matanasarawut, Wanmanee
    Wannapira, Wiroj
    Lallemant, Marc
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2009, 35 (02) : 225 - 233
  • [3] Risk factors associated with preterm delivery and low delivery weight among HIV-exposed neonates in China
    Wang, Liming
    Zhao, Hongxin
    Cai, Weiping
    Tao, Jie
    Zhao, Qingxia
    Sun, Lijun
    Fan, Qingbo
    Kourtis, Athena P.
    Shepard, Colin
    Zhang, Fujie
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2018, 142 (03) : 300 - 307
  • [4] PRETERM BIRTH AND FETAL GROWTH RESTRICTION IN HIV-INFECTED BRAZILIAN PREGNANT WOMEN
    Barroso Dos Reis, Helena Lucia
    Araujo, Karina da Silva
    Ribeiro, Lilian Paula
    Da Rocha, Daniel Ribeiro
    Rosato, Drielli Petri
    Leal Passos, Mauro Romero
    Mercon De Vargas, Paulo Roberto
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2015, 57 (02): : 111 - 120
  • [5] Determinants of low birth weight among HIV-infected pregnant women in Tanzania
    Dreyfuss, ML
    Msamanga, GI
    Spiegelman, D
    Hunter, DJ
    Urassa, EJN
    Hertzmark, E
    Fawzi, WW
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2001, 74 (06): : 814 - 826
  • [6] Inflammatory Markers Related to Microbial Translocation Among HIV-Infected Pregnant Women: A Risk Factor of Preterm Delivery
    Lopez, Marta
    Figueras, Francesc
    Coll, Oriol
    Gonce, Anna
    Hernandez, Sandra
    Lonca, Montse
    Vila, Jordi
    Gratacos, Eduard
    Palacio, Montse
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (03): : 343 - 350
  • [7] Antiretroviral therapy and preterm birth in HIV-infected women
    Short, Charlotte-Eve S.
    Taylor, Graham P.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (03) : 293 - 306
  • [8] Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study
    Li, Nan
    Sando, Mary Mwanyika
    Spiegelman, Donna
    Hertzmark, Ellen
    Liu, Enju
    Sando, David
    Machumi, Lameck
    Chalamilla, Guerino
    Fawzi, Wafaie
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (07): : 1057 - 1064
  • [9] Risk Factors for Preterm Birth Among HIV-Infected Pregnant Ugandan Women Randomized to Lopinavir/Ritonavir- or Efavirenz-Based Antiretroviral Therapy
    Koss, Catherine A.
    Natureeba, Paul
    Plenty, Albert
    Luwedde, Flavia
    Mwesigwa, Julia
    Ades, Veronica
    Charlebois, Edwin D.
    Clark, Tamara D.
    Achan, Jane
    Ruel, Theodore
    Nzarubara, Bridget
    Kamya, Moses R.
    Havlir, Diane V.
    Cohan, Deborah
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 (02) : 128 - 135
  • [10] Highly Active Antiretroviral Therapy and Adverse Birth Outcomes Among HIV-Infected Women in Botswana
    Chen, Jennifer Y.
    Ribaudo, Heather J.
    Souda, Sajini
    Parekh, Natasha
    Ogwu, Anthony
    Lockman, Shahin
    Powis, Kathleen
    Dryden-Peterson, Scott
    Creek, Tracy
    Jimbo, William
    Madidimalo, Tebogo
    Makhema, Joseph
    Essex, Max
    Shapiro, Roger L.
    JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (11): : 1695 - 1705